ENVALITH
OATアグリオ株式会社 logo

OAT Agrio Co., Ltd.

4979・Standard Market・Chemicals

Official website
OATアグリオ株式会社 logo
OAT Agrio Co., Ltd.4979

Business

OAT Agrio Co., Ltd. upholds the management philosophy of "contributing to people around the world through food production increase technology (agritechnology) and sincerity," and provides agricultural solutions across three technology domains: agrochemicals (pest control technology), fertilizers (fertigation technology), and biostimulants. Domestically, the company maintains a sales structure via Zen-Noh and commercial distributors, while overseas it operates through 29 consolidated subsidiaries (including Blue Wave Holding B.V. in the Netherlands, LIDA Plant Research S.L. in Spain, and OAT&IIL India Laboratories in India, among others), expanding across Asia, Europe, Latin America, and Africa. Its main customers are greenhouse horticulture farmers, agricultural corporations, and agricultural materials distributors, with Maruzen Pharmaceuticals Industry being its largest customer, accounting for 16.2% of net sales. Net sales for FY2025 (ending December 2025) were ¥31,950 million.

Business Model

Centered on the R&D laboratory, plant, and cultivation research center in Naruto City, Tokushima Prefecture, the company conducts in-house development end-to-end, from active ingredient synthesis through screening, formulation, and agrochemical registration, and monetizes this through sales channels comprising Zen-Noh, commercial distributors, and group subsidiaries. The Fertilizer & Biostimulant Products (Fertigation Technology) segment (net sales of ¥19,950 million, 62.4% of total) has grown to exceed the scale of the Agrochemical Products (Pest Control Technology) segment (¥11,786 million). The company continues to invest ¥2,662 million in R&D expenses (8.3% of net sales) to sustain its new product pipeline.

Company Strengths

A key differentiator is the ability to provide Agrochemical Products (Pest Control Technology), Fertilizer (Fertigation Technology), and Biostimulants across three domains under a single group. The company has a framework to propose total solutions—rather than standalone products—to farmers, such as "Agrio Ichigo Master," which combines its nutrient-solution soil cultivation system (cumulative sales of approximately 3,000 units, with a track record of over 25 years) with AI-based growth diagnostics.

The company holds a lineup of Organic JAS-compliant "Green Products" derived from natural and food-additive sources (Calcium Green, Akari Touch, Saf Oil, etc.), and has obtained OMRI organic certification for "Calcium Green" in the United States. Expanding sales volumes have been confirmed in the domestic apple and citrus markets, and the company has already built a product portfolio capable of responding to growing demand for organic and environmentally conscious agriculture.

The company maintains three R&D sites: Naruto City, Tokushima Prefecture (domestic), India (OAT&IIL India Laboratories), and Spain (LIDA Plant Research S.L.). R&D expenses for FY2025 (ending December 2025) totaled ¥2,662 million (8.3% of sales), with continued investment in the development of new chemically synthesized pest control materials, Green Products, and biostimulants.

ENVALITH's Perspective

In Q1 of FY2026 (ending December 2026), net sales were ¥9,963 million (up 13.7% year on year), operating profit was ¥1,882 million (up 27.3%), and quarterly net profit attributable to owners of the parent was ¥1,293 million (up 38.8%), achieving double-digit growth across all metrics. Against the full-year forecast (net sales of ¥33,820 million, operating profit of ¥3,800 million), the Q1 progress rate stood at a high 29.5% for net sales and 49.5% for operating profit. However, it should be noted that Q1 seasonally tends to have a higher profit margin due to concentrated shipments ahead of the peak farming season, and the company has not revised its full-year forecast.

The foreign exchange loss of ¥122 million recorded in the same period of the previous year fell to zero in the current period, and instead a foreign exchange gain of ¥26 million was recorded. Equity-method investment income also expanded from ¥6 million to ¥17 million. These external factors and affiliate-related factors constitute part of the 40.2% year-on-year increase (up ¥545 million) in recurring profit, and need to be identified as an additional boost on top of the improvement in core operating profit (up ¥403 million). Continued attention should be paid to changes in the foreign exchange environment as an ongoing risk factor for future earnings volatility.

The equity ratio at the end of Q1 of FY2026 (ending December 2026) stood at 49.4%, down from 50.4% at the end of the previous fiscal year. Short-term borrowings increased by ¥1,329 million, from ¥7,784 million to ¥9,114 million, reflecting a structure in which working capital needs arising from an increase in accounts receivable (up ¥1,877 million) are being funded through short-term borrowings. While this reflects seasonal funding needs during the peak farming season, an increasing reliance on borrowings could become a cost-increasing factor in a rising interest rate environment (an external factor). Net assets increased to ¥20,984 million, and while this is not immediately a level of concern, the trend warrants continued monitoring.

Growth Strategy

Targeting net sales of ¥33,820 million in FY2026 through four pillars: green products, biostimulants, smart agriculture, and global expansion

Natural and organic JAS-compliant agrochemicals such as "Safuoil" and "Tomonol" are being rolled out both domestically and overseas. In Q1 of FY2026 (ending December 2026), sales increased year on year, contributing to a 19.9% increase in the agrochemical segment overall. Continued growth is expected against the backdrop of expanding demand for environmentally conscious agriculture.

Four products—"Entenmaster," "Reddavital," "Algamix," and "Fulvody"—recorded strong sales in Q1 of FY2026 (ending December 2026), contributing to net sales of ¥5,572 million (up 9.4% year on year) in the Fertilizer & Biostimulant Products (Fertigation Technology) segment. The company continues to develop the market by leveraging its first-mover advantage in the new category of plant immune activation.

Three overseas affiliates—LIDA Plant Research in Spain, Asahi Chemical Europe in the Czech Republic, and PT. OAT MITOKU AGRIO in Indonesia—maintained solid performance in Q1 of FY2026 (ending December 2026). Overseas sales reached ¥7,044 million, maintaining a high overseas ratio of 70.7% of total sales. Overseas expansion of agrochemical products such as "Danisaraba" and "Oncol" is also progressing steadily.

The company has positioned circular hydroponic cultivation utilizing unused biological resources (probioponics) and smart agriculture (leveraging AI and sensing technologies) as priority businesses, continuing active investment toward the final year of the new Medium-Term Management Plan (2024-2026). While sales contribution remains limited at present, these areas are being cultivated as medium- to long-term growth drivers.

Last updated: July 17, 2026